EVOMMUNE - PHASE 1 TRIAL FOR EVO570 EXPECTED TO BEGIN IMMINENTLY; PHASE 2 IN RHEUMATOID ARTHRITIS PLANNED FOR 2027

Reuters · 12h ago

Please log in to view news